ALT – Altimmune Inc
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
22.5
Margin Of Safety %
Put/Call OI Ratio
0.26
EPS Next Q Diff
-0.95
EPS Last/This Y
0.35
EPS This/Next Y
-0.33
Price
5.24
Target Price
16.86
Analyst Recom
1.75
Performance Q
41.24
Relative Volume
0.89
Beta
Ticker: ALT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | ALT | 4.25 | 0.22 | 0.42 | 231971 |
| 2025-11-11 | ALT | 4.28 | 0.22 | 1.51 | 235184 |
| 2025-11-12 | ALT | 4.23 | 0.23 | 1.46 | 238628 |
| 2025-11-13 | ALT | 4.05 | 0.23 | 0.23 | 240244 |
| 2025-11-14 | ALT | 4.16 | 0.23 | 0.20 | 240729 |
| 2025-11-17 | ALT | 4.2 | 0.24 | 0.18 | 232070 |
| 2025-11-18 | ALT | 4.64 | 0.24 | 0.53 | 234346 |
| 2025-11-19 | ALT | 4.59 | 0.23 | 0.26 | 238365 |
| 2025-11-20 | ALT | 4.47 | 0.24 | 0.10 | 239946 |
| 2025-11-21 | ALT | 4.8 | 0.23 | 0.05 | 240957 |
| 2025-11-24 | ALT | 5.08 | 0.24 | 0.07 | 224205 |
| 2025-11-25 | ALT | 5.14 | 0.24 | 0.16 | 231537 |
| 2025-11-26 | ALT | 5.18 | 0.24 | 0.12 | 235764 |
| 2025-12-01 | ALT | 4.93 | 0.24 | 0.54 | 236948 |
| 2025-12-02 | ALT | 4.76 | 0.26 | 0.16 | 243752 |
| 2025-12-03 | ALT | 5.14 | 0.26 | 0.18 | 245660 |
| 2025-12-04 | ALT | 5.31 | 0.26 | 0.14 | 247828 |
| 2025-12-05 | ALT | 5.24 | 0.26 | 0.34 | 248714 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | ALT | 4.26 | 17.0 | -93.5 | -1.13 |
| 2025-11-11 | ALT | 4.28 | 17.0 | -88.4 | -0.99 |
| 2025-11-12 | ALT | 4.23 | 17.0 | -83.4 | -0.99 |
| 2025-11-13 | ALT | 4.06 | 17.0 | -74.9 | -0.99 |
| 2025-11-14 | ALT | 4.17 | 24.7 | -95.5 | -0.99 |
| 2025-11-17 | ALT | 4.20 | 24.7 | -89.5 | -0.99 |
| 2025-11-18 | ALT | 4.64 | 24.7 | -119.8 | -0.99 |
| 2025-11-19 | ALT | 4.59 | 24.7 | -82.9 | -0.99 |
| 2025-11-20 | ALT | 4.46 | 24.7 | -78.6 | -0.99 |
| 2025-11-21 | ALT | 4.79 | 24.7 | -108.0 | -0.99 |
| 2025-11-24 | ALT | 5.07 | 24.7 | -101.8 | -0.99 |
| 2025-11-25 | ALT | 5.14 | 24.7 | -90.4 | -0.99 |
| 2025-11-26 | ALT | 5.18 | 24.7 | -88.9 | -0.99 |
| 2025-12-01 | ALT | 4.93 | 24.7 | -70.2 | -0.99 |
| 2025-12-02 | ALT | 4.76 | 24.7 | -77.5 | -0.99 |
| 2025-12-03 | ALT | 5.11 | 24.7 | -107.2 | -0.99 |
| 2025-12-04 | ALT | 5.31 | 24.7 | -97.6 | -0.99 |
| 2025-12-05 | ALT | 5.24 | 24.7 | -83.7 | -0.99 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | ALT | 0.00 | -3.08 | 24.56 |
| 2025-11-11 | ALT | 0.00 | -3.08 | 0 |
| 2025-11-12 | ALT | 0.00 | -3.08 | 21.04 |
| 2025-11-13 | ALT | 0.00 | -3.08 | 21.04 |
| 2025-11-14 | ALT | 0.00 | -3.08 | 21.04 |
| 2025-11-17 | ALT | 0.00 | -1.07 | 21.04 |
| 2025-11-18 | ALT | 0.00 | -1.07 | 21.04 |
| 2025-11-19 | ALT | 0.00 | -1.07 | 21.04 |
| 2025-11-20 | ALT | 0.00 | -1.07 | 21.04 |
| 2025-11-21 | ALT | 0.00 | -1.07 | 21.04 |
| 2025-11-24 | ALT | 0.00 | 3.95 | 21.04 |
| 2025-11-25 | ALT | 0.00 | 3.95 | 21.04 |
| 2025-11-26 | ALT | 0.00 | 3.95 | 22.50 |
| 2025-12-01 | ALT | 0.00 | 3.90 | 22.50 |
| 2025-12-02 | ALT | 0.00 | 3.90 | 22.50 |
| 2025-12-03 | ALT | 0.00 | 3.90 | 22.50 |
| 2025-12-04 | ALT | 0.00 | 3.90 | 22.50 |
| 2025-12-05 | ALT | 0.00 | 3.90 | 22.50 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT
589 360 ]
Last Quarter Act. EPS
0.67
Avg. EPS Est. Current Quarter
-0.25
Avg. EPS Est. Next Quarter
-0.28
Insider Transactions
Institutional Transactions
3.9
Beta
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
24
Growth Score
23
Sentiment Score
39
Actual DrawDown %
78.7
Max Drawdown 5-Year %
-91.2
Target Price
16.86
P/E
Forward P/E
PEG
P/S
27337.8
P/B
2.7
P/Free Cash Flow
EPS
-1.07
Average EPS Est. Cur. Y
-0.99
EPS Next Y. (Est.)
-1.32
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-419575
Relative Volume
0.89
Return on Equity vs Sector %
-72.1
Return on Equity vs Industry %
-57.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.14
EBIT Estimation
-83.7
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT
589 450 ]
Altimmune, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT
premarket after hours
ticker ALT
fair value insiders trading